Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Patient Education and Counseling|November 28, 2001
The decisional conflict scale: further validation in two samples of Dutch oncology patientsN Koedoot, S Molenaar, P Oosterveld, et al.Gynecologic Oncology|July 1, 1988
The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosisA P Heintz, A T Van Oosterom, J B Trimbos, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinomaC H Veenhof, M E van der Burg, M Nooy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma IntergroupD Ornadel, R L Souhami, J Whelan, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group studyE Tomiak, M Piccart, F Mignolet, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomyE Pujade-Lauraine, J P Guastalla, N Colombo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapyA N Wymenga, W T van der Graaf, J A Wils, et al.Pageof 1